26 October 2025
Hogan Lovells advises EyePoint on its US$150 million follow-on public offering of equity securities
Advising firms
Deal team
4 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Stephen Nicolai Lead | Hogan Lovells Cadwalader | Partner | Not stated | Philadelphia |
| Kayvon Paul | Hogan Lovells Cadwalader | Associate | Not stated | Philadelphia |
| Athira Sivan | Hogan Lovells Cadwalader | Associate | Not stated | Philadelphia |
| Diane Shin | Hogan Lovells Cadwalader | Trainee | Not stated | New York |
1 more lawyer on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 150m (US$150 million)
- What the figure measures
- Issue size
- Client
- EyePoint Pharmaceuticals, Inc.Issuer
- Counterparties
- Not stated